For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
A phospho specific peptide corresponding to residues surrounding serine 63 of human ATF1
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
A trial size is available to purchase for this antibody.
Our Abpromise guarantee covers the use of ab76085 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent concentration. PubMed: 22052915|
|WB||1/50000 - 1/100000. Predicted molecular weight: 29 kDa.|
|IHC-P||1/100 - 1/250.|
|ICC||1/100 - 1/250.|